An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis
Clinical trial NCT06849778 · COMPLETED
Trial details
- NCT number
- NCT06849778
- Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-22
- Primary completion
- 2025-04-24
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.